Tucson Drug Startup Launches Gastric-Cancer Trial
AZ Daily Star

Tucson-based drug startup Cancer Prevention Pharmaceuticals Inc. has announced the launch of a Phase 2 clinical trial at Vanderbilt University Medical Center to test the company’s flagship drug candidate for preventing gastric cancer. The company was co-founded by BIO5 Institute member and Cancer Center member Dr. Eugene Gerner.